ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carroll, T. A
Right arrow Articles by Carroll, W. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carroll, T. A
Right arrow Articles by Carroll, W. E
Annals of Clinical & Laboratory Science 33:113-114 (2003)
© 2003 Association of Clinical Scientists


Brief Communication

Probability and the Westgard Rules

Tomás A Carroll1, Heather A Pinnick2 and Wallace E Carroll2
1 Phillips Petroleum Corporation, Borger, Texas
2 Department of Pathology, Santa Barbara Cottage Hospital, Santa Barbara, California

Address correspondence to Wallace E. Carroll, M.D., 1556 San Leandro Lane, Montecito, CA 93108, USA; tel 805 969 2758; fax 805 969 3796; e-mail wallml{at}cox.net.

Abstract

Shewhart introduced industry to the concept of three standard deviation (3S) limits for quality control and Levey, Jennings, Henry, and Westgard adapted this idea to clinical laboratory medicine. Westgard ultimately formulated a system of rules to enable clinical laboratory scientists to decide whether the tests they were doing were "in control" and reportable, or "out of control." The present communication explains mathematically how Shewhart’s "beyond 3S" (ie, >1 chance in 370) is an indication for corrective laboratory action.

Keywords: quality assurance, Westgard’s rules, probability, clinical laboratory testing







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association of Clinical Scientists.